Technical Analysis for GMED - Globus Medical, Inc.
|Grade||Last Price||% Change||Price Change|
GMED closed up 1.33 percent on Friday, January 18, 2019, on 52 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
|See historical GMED trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Jan 18||Narrow Range Bar||Range Contraction||0.00%|
|Jan 18||NR7||Range Contraction||0.00%|
|Jan 18||NR7-2||Range Contraction||0.00%|
|Jan 18||Up 3 Days in a Row||Strength||0.00%|
|Jan 18||Up 4 Days in a Row||Strength||0.00%|
|Jan 17||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||1.33%|
|Jan 17||Calm After Storm||Range Contraction||1.33%|
|Jan 17||NR7||Range Contraction||1.33%|
|Jan 17||Inside Day||Range Contraction||1.33%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of products that promote healing in patients with spine disorders. It offers approximately 100 innovative fusion and disruptive technology products that address an array of spinal pathologies, anatomies, and surgical approaches. The company's innovative fusion products are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Its disruptive technology products provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies. The company's products under clinical development include SECURE-C Cervical Artificial Disc, an artificial disc designed to alleviate pain and preserve motion in patients with symptomatic cervical disc disease; ACADIA Facet Replacement System, which allows for an anatomic reconstruction of the facet joint after the degenerated facet is decompressed and removed; and TRIUMPH Lumbar Disc that is used in the treatment of lumbar degenerative disc disease. Globus Medical, Inc. sells its implants and related disposables primarily to hospitals. The company markets and sells its products through sales representatives and independent distributors in the United States and 17 countries internationally. Globus Medical, Inc. was founded in 2003 and is based in Audubon, Pennsylvania.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more GMED news...
|52 Week High||57.83|
|52 Week Low||38.01|
|200-Day Moving Average||50.9278|
|50-Day Moving Average||46.1786|
|20-Day Moving Average||41.7325|
|10-Day Moving Average||41.904|
|Average True Range||1.7193|
|Chandelier Exit (Long, 3 ATRs )||40.7921|
|Chandelier Exit (Short, 3 ATRs )||43.1679|
|Upper Bollinger Band||44.8632|
|Lower Bollinger Band||38.6018|
|Percent B (%b)||0.78|
|MACD Signal Line||-1.4262|
|Market Cap||4.18 Billion|
|Num Shares||96.2 Million|
|Price-to-Earnings (P/E) Ratio||39.18|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||44.59|
|Resistance 3 (R3)||44.50||44.04||44.40|
|Resistance 2 (R2)||44.04||43.76||44.09||44.34|
|Resistance 1 (R1)||43.77||43.59||43.91||43.86||44.28|
|Support 1 (S1)||43.04||43.03||43.18||43.13||42.70|
|Support 2 (S2)||42.58||42.86||42.63||42.64|
|Support 3 (S3)||42.31||42.58||42.58|
|Support 4 (S4)||42.40|